![Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society](https://mms.businesswire.com/media/20220512005129/en/739014/23/teva_RGB_JPEG.jpg)
Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
Teva Pharmaceuticals on Twitter: "This month is National Asthma and Allergy Awareness Month and identifying and avoiding #asthma triggers is an important part of asthma management. Read and learn more here: https://t.co/CkL08njkXr #
Teva Pharmaceutical Industries Ltd. - Did you know that 4.5 to 5.9 million Americans suffer from a severe form of #asthma called #eosinophilic asthma? Learn more about the condition in this infographic! #WorldAsthmaDay | Facebook
![Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel](https://img.medicalexpo.com/images_me/projects/images-g/teva-s-proair-digihaler-fda-approved-to-monitor-asthma-copd-treatment-26785-13464157.jpg)
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
![Teva Pharmaceutical touts real-world data on ProAir Digihaler for asthma (NYSE:TEVA) | Seeking Alpha Teva Pharmaceutical touts real-world data on ProAir Digihaler for asthma (NYSE:TEVA) | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304488209/image_1304488209.jpg?io=getty-c-crop-4-3)
Teva Pharmaceutical touts real-world data on ProAir Digihaler for asthma (NYSE:TEVA) | Seeking Alpha
![Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com](https://media.snacksafely.com/wp-content/uploads/2019/07/Digihaler-1068x559.jpg)